Hepatitis B surface antigen (HBsAg) prevalence in Cabo Verde
Cabo Verde: Hepatitis B surface antigen (HBsAg) prevalence was 0.7% in 2024. ▼ Falling
Latest (2024)
0.7%
Change on year
up 16.7%
World rank
43rd
of 194 countries
All-time high
1.0%
in 2016
All-time low
0.6%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Cabo Verde, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Cabo Verde is 0.7%, measured in 2024.
The figure is up 16.7% on the previous year and down 22.2% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Cabo Verde peaked at 1.0% in 2016 and was at its lowest, 0.6%, in 2020.
That places Cabo Verde 43rd out of 194 countries with data for 2024, putting it in the top quarter.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.8% | 0.7% | 1.0% | 5 |
| 2020s | 0.6% | 0.6% | 0.7% | 5 |
Countries ranked near Cabo Verde
- 43 Sierra Leone 0.7% compare
- 43 Benin 0.7% compare
- 43 Burkina Faso 0.7% compare
- 43 Brunei Darussalam 0.7% compare
- 43 Indonesia 0.7% compare
- 43 Kenya 0.7% compare
- 43 Liberia 0.7% compare
More health data for Cabo Verde
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.747 % change on previous year (2090)
- Heat deaths vs projected death rates 1,578 (2090)
- Un projection of annual infant deaths 6 (2100)
- Population ages 65 and above, total, annual growth rate 4.8 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.0715 units per person (2025)
- Population, female, annual growth rate 0.4815 % change on previous year (2025)
- Population, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population, female, per capita 0.4915 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Cabo Verde?
- Hepatitis b surface antigen (hbsag) prevalence in Cabo Verde was 0.7% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Cabo Verde?
- The highest recorded value was 1.0% in 2016.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Cabo Verde?
- The lowest recorded value was 0.6% in 2020.
- How does Cabo Verde rank for hepatitis b surface antigen (hbsag) prevalence?
- Cabo Verde ranks 43rd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Cabo Verde?
- Over the last ten years it is down 22.2%. The long-run trend across the full record is falling.
- Where does this Cabo Verde data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).